Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per the Regulation 39(3) of SEBI (Listing obligations and disclosure requirement), Regulation 2015, we have received request from the shareholder for issue of Duplicate Share Certificate and accordingly RTA of the Company has marked stop transfer until Duplicate Share Certificate is issued. Zim Laboratories Ltd - 541400 - Fixes Book Closure for AGM
Zim Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2020 to September 30, 2020 (both days inclusive) for the purpose of 36th Annual General Meeting (AGM) of the Company to be held on September 30, 2020. Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the request received from shareholders, the Company has issued Duplicate Share Certificates ain place of Share Certificate lost / misplaced etc., by the said shareholders. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith a copy of newspaper advertisements published in respect of 36th Annual General Meeting of the Company scheduled to be held on 30th September, 2020, in The Financial Express (English) all India Edition, Indian Express, Nagpur Edition and Loksatta (Marathi) Newspaper dated 09.09.2020 Zim Laboratories Ltd - 541400 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find the enclosed herewith updated Annual Report for the Financial Year 2019-20 along with the Notice of the 36th Annual General Meeting to be held on Wednesday, 30th September, 2020 at 11.00 a.m. IST through Video Conferencing ('VC') in place of our earlier disclosure submitted on 08.09.2020. All the stakeholders are requested to consider this disclosure as the final disclosure under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. We regret the inconvenience caused to any stakeholder in this regard. Zim Laboratories Ltd - 541400 - Submission Of Notice Of 36Th Annual General Meeting Of The Company Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 'SEBI (LODR)'
Pursuant to Regulation 30 read with Part A of schedule III of the SEBI (LODR) Regulations, 2015, enclosed herewith is the Notice of 36th Annual General Meeting of the company scheduled to be held on 30th September, 2020 at 11:00 a.m. through Video Conferencing ('VC') / Other Audio-Visual Means('OAVM'). Zim Laboratories Ltd - 541400 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find the enclosed herewith Annual Report for the Financial Year 2019-20 along with the Notice of the 36th Annual General Meeting to be held on Wednesday, 30th September, 2020 at 11.00 a.m. IST through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of the notice published on Friday, 28th August, 2020 in the following newspapers for the attention of the equity shareholders of the Company in respect of registration of Email Id, Mobile Number and Bank Account Details by the shareholders of the company: 1) Financial Express (English) - All India Edition; 2) Loksatta - Nagpur district. You are requested to kindly take the above information on your records. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith the press release related to signing of exclusive licensing agreement for VITAMIN D3 Orally Dispersible Film with Brazil based HYPERA Pharma Group. Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per the Regulation 39(3) of SEBI (Listing obligations and disclosure requirement), Regulation 2015, we have received request from the shareholder for issue of Duplicate Share Certificate and accordingly RTA of the Company has marked stop transfer until Duplicate Share Certificate is issued Kindly take the intimation on record.